8-K: USANA Health Sciences Acquires Controlling Stake in Hiya Health Products for $205 Million

USANA Health Sciences has acquired a 78.8% controlling interest in Hiya Health Products, a direct-to-consumer children's health and wellness company, for $205 million in cash.

Summary

• USANA Health Sciences has acquired a 78.8% controlling stake in Hiya Health Products for $205 million in cash.
• Hiya is a direct-to-consumer online retail business specializing in children's vitamins, minerals, and supplements.
• The total consideration of $205 million was funded with $200 million from cash on hand and the remainder from USANA's existing credit facility.
• USANA deposited a portion of the consideration in escrow to secure indemnification obligations and post-closing adjustments.
• Hiya generated $103 million in net sales, $19 million in net income, and $22 million in adjusted EBITDA for the last twelve months ended September 30, 2024.
• Hiya has over 200,000 customers as of September 30, 2024.
• The acquisition is expected to be immediately accretive to USANA's 2025 adjusted EBITDA.
• USANA was issued Class A units of the surviving company equal to 78.85% of the membership interests.
• Qualified Hiya unitholders received cash and Class B units equal to 21.15% of the membership interests.
• Non-qualified Hiya unitholders received cash consideration.
• Options to acquire membership interests in Hiya were cancelled and holders received cash consideration.

Sentiment

Score: 8

Explanation: The document conveys a positive outlook on the acquisition, highlighting the strategic fit, growth potential, and financial benefits. The language used is optimistic and confident, suggesting a strong positive sentiment.

Positives

• The acquisition is expected to be immediately accretive to USANA's 2025 adjusted EBITDA.
• Hiya's direct-to-consumer model diversifies USANA's distribution channels.
• Hiya's subscription model provides attractive margins, profitability, and cash flow generation.
• The acquisition expands USANA's presence in the growing children's health and wellness market.
• Hiya's domestic profitability is expected to lower USANA's consolidated effective tax rate.
• There are opportunities for synergies between USANA and Hiya, including leveraging USANA's manufacturing and international expansion expertise and Hiya's marketing expertise and children-focused products.
• Hiya has a strong growth strategy to become the #1 children's wellness platform.

Risks

• The integration of Hiya's business with USANA's business may be challenging.
• There are risks associated with the diversion of management's attention from ongoing business operations.
• There is a risk that USANA may not realize the expected benefits of the acquisition, including synergies and cost savings.
• There are risks associated with the potential loss of key personnel from Hiya.
• The transaction structure includes a put/call feature that provides for USANAs acquisition of the remaining rollover equity at a pre-negotiated valuation scale, which is based on Hiyas financial performance, which may not be favorable to USANA.

Future Outlook

USANA anticipates Hiya's net sales growth to approach 30% year-over-year for fiscal year 2025 and expects the acquisition to be accretive to its 2025 adjusted EBITDA. USANA and Hiya will work together to leverage synergies and accelerate growth and profitability.

Management Comments

• Jim Brown, President and CEO of USANA, stated that the acquisition represents a key strategic milestone and adds a diversified layer of growth to USANA's business.
• Darren Litt, co-founder and CEO of Hiya, expressed excitement about joining the USANA family and extending their commitment to healthy products for more families in more countries.

Industry Context

This acquisition reflects a trend of established companies acquiring fast-growing direct-to-consumer brands to expand their reach and diversify their revenue streams. The children's health and wellness market is a growing sector, making Hiya an attractive target for USANA.

Comparison to Industry Standards

• Hiya's 50% net sales growth in the last twelve months ended September 30, 2024, compared to fiscal year 2023, indicates a strong performance relative to industry averages.
• Hiya's subscription model and attractive margins are comparable to other successful direct-to-consumer brands in the health and wellness space.
• The acquisition of Hiya by USANA is similar to other strategic acquisitions in the consumer goods sector, where established companies acquire emerging brands to expand their market reach and product offerings.
• The $205 million cash transaction for a 78.8% stake in Hiya is a significant investment, reflecting the value USANA sees in Hiya's brand and growth potential.

Management Changes

Stakeholder Impact

• Shareholders: The acquisition is expected to be accretive to USANA's 2025 adjusted EBITDA and enhance long-term growth and shareholder value.
• Employees: Hiya's co-founders and management team will remain in place, ensuring continuity and expertise.
• Customers: The acquisition will allow USANA to reach a broader audience and provide more families with access to high-quality nutritional products.
• Suppliers: The acquisition may lead to new opportunities for suppliers as USANA and Hiya integrate their operations.
• Creditors: The transaction was financed with cash on hand and a draw on USANA's existing credit facility.

Next Steps

• USANA and Hiya will work together to leverage synergies and accelerate growth and profitability.
• Hiya will leverage USANA's manufacturing and international expansion expertise.
• USANA may leverage Hiya's market data insights, marketing expertise, and children-focused products within its direct sales channel.
• Hiya plans to expand into new product introductions, channel expansion, and geographic expansion.

Key Dates

Keywords

acquisition, USANA, Hiya Health, direct-to-consumer, children's health, wellness, vitamins, supplements, subscription model, EBITDA, merger